Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 58 citing articles:

Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?
Dimitrios Giannis, James D. Douketis, Alex C. Spyropoulos
European Journal of Internal Medicine (2021) Vol. 96, pp. 13-16
Open Access | Times Cited: 9
Optimal thromboprophylaxis strategies in non-critically ill patients with COVID-19 pneumonia. The PROTHROMCOVID Randomized Controlled Trial
Nuria Muñoz‐Rivas, Jesús Aibar, Cristina Gabara-Xancó, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
3D-PAST: Risk Assessment Model for Predicting Venous Thromboembolism in COVID-19
Yi Lee, Qasim Jehangir, Chun‐Hui Lin, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 14, pp. 3949-3949
Open Access | Times Cited: 6
Clinical Outcomes of Anticoagulant Therapy in COVID-19 Patients with Pre-Existing Cardiovascular Diseases: A Systematic Review
Naif M. Alhawiti, Jamal M Alhawiti, Saif Alshalan, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 3767-3775
Open Access | Times Cited: 3
Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes
Mengdi Li, Xiaoming Wu, Jialan Shi, et al.
Endocrine (2023) Vol. 82, Iss. 1, pp. 15-27
Closed Access | Times Cited: 3
COVID-19 thromboprophylaxis. New evidence
Raquel Ferrandis, P. Sierra, A. Gómez‐Luque
Revista Española de Anestesiología y Reanimación (English Edition) (2023) Vol. 71, Iss. 1, pp. 34-47
Closed Access | Times Cited: 3
Global lessons learned from COVID-19 mass casualty incidents
Marcus J. Schultz, Oriol Roca, Gentle Sunder Shrestha
British Journal of Anaesthesia (2021) Vol. 128, Iss. 2, pp. e97-e100
Open Access | Times Cited: 8
Association between Thrombin Generation and Clinical Characteristics in COVID-19 Patients
Omri Cohen, Nitsan Landau, Einat Avisahai, et al.
Acta Haematologica (2022) Vol. 146, Iss. 2, pp. 151-160
Open Access | Times Cited: 5
Effectiveness and safety of rivaroxaban for anticoagulation therapy in COVID-19
X. Shen, Eryue Qiu, Zhao Liu, et al.
Saudi Medical Journal (2024) Vol. 45, Iss. 4, pp. 341-348
Open Access
Long COVID-19 and the potential use of palmitoylethanolamide
Rocco Salvatore Calabrò, Loredana Raciti
Elsevier eBooks (2024), pp. 429-439
Closed Access
Thrombotic complications in children and adolescents with SARS-CoV-2 infection
Clay T. Cohen, Dalia Bashir, Sarah E. Sartain
Elsevier eBooks (2024), pp. 531-548
Closed Access
Determination of rivaroxaban in rat plasma by ultra‐high‐performance liquid chromatography–Q‐Orbitrap high‐resolution mass spectrometry and its application to a pharmacokinetic study
Jing Qian, Shunzhong Gu, Yong‐jin Yan
Biomedical Chromatography (2022) Vol. 36, Iss. 12
Closed Access | Times Cited: 3
Post COVID-19 sequelae of the respiratory system. A single center experience reporting the compromise of the airway, alveolar and vascular components
Nousheen Iqbal, Iffat Khanum, Muhammad Ali Ibrahim Kazi, et al.
Monaldi Archives for Chest Disease (2022)
Open Access | Times Cited: 3
Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19
Michael R. Cook, Kaitlyn C Dykes, Katherine White, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 22, Iss. 7, pp. e452-e458
Open Access | Times Cited: 4
Rivaroxaban to Prevent Major Clinical Outcomes in Non-Hospitalised Patients with COVID-19: The Care – Coalition VIII Randomised Clinical Trial
Álvaro Avezum, Haliton Alves de Oliveira, Precil Diego Miranda de Menez Neves, et al.
(2023)
Open Access | Times Cited: 1
Management of acute COVID-19 in the pediatric population and role of antimicrobial therapy
Helen Groves, U. Allen, Susan Morris
Elsevier eBooks (2023), pp. 99-139
Closed Access | Times Cited: 1
Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID‐19 infection
Dorit Blickstein, Marina Izak, Talia Filipovich‐Rimon, et al.
Vox Sanguinis (2023) Vol. 118, Iss. 7, pp. 517-522
Closed Access | Times Cited: 1
Coronavirus disease 2019-associated thrombotic microangiopathy treated with plasma exchange and antihypertensive therapy in a patient with HIV: A case report with literature review
Eriko Masuda, Kazuaki Fukushima, Yu Hebisawa, et al.
Medicine (2023) Vol. 102, Iss. 41, pp. e35469-e35469
Open Access | Times Cited: 1
To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question
Behnood Bikdeli
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 4, pp. e12738-e12738
Open Access | Times Cited: 2
Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies
Maha AT Elsebaie, Binav Baral, Mai Alaaeldin Temraz Elsebaie, et al.
TH Open (2022) Vol. 06, Iss. 04, pp. e323-e334
Open Access | Times Cited: 2
Use of Systemic Anticoagulation in COVID-19: Delving Beyond Theoretical Hypothesis
Christopher Millet, Spandana Narvaneni, Fady Shafeek, et al.
Cureus (2022)
Open Access | Times Cited: 1
Higher Dose Anticoagulation Cannot Prevent Disease Progression in COVID-19 Patients: A Systematic Review and Meta-Analysis
Emőke Henrietta Kovács, Krisztián Tánczos, L. Szabó, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2194-2194
Open Access | Times Cited: 1
Thrombotic Events and Anticoagulation-Related Bleeding Complications in Critically Ill Patients with Coronavirus Disease 2019
Mayur Narayan, Nicole E. Leahy, Dalia Alqunaibit, et al.
Surgical Infections (2022) Vol. 23, Iss. 8, pp. 705-711
Closed Access | Times Cited: 1
Tromboprofilaxis en COVID-19. Nuevas evidencias
Raquel Ferrandis, P. Sierra, A. Gómez‐Luque
Revista Española de Anestesiología y Reanimación (2023) Vol. 71, Iss. 1, pp. 34-47
Closed Access
Diagnosis and treatment of coagulopathy using thromboelastography with platelet mapping is associated with decreased risk of pulmonary failure in COVID-19 patients
Tjasa Hranjec, Mackenzie Mayhew, Bradley Rogers, et al.
Blood Coagulation & Fibrinolysis (2023) Vol. 34, Iss. 8, pp. 508-516
Closed Access

Scroll to top